RXO (RXO) reported a Q1 adjusted loss of $0.03 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected a loss of $0.02.

Revenue for the quarter ended March 31 was $1.43 billion, up from $913 million a year earlier.

Analysts surveyed by FactSet expected $1.49 million.

The company said it expects Q2 adjusted earnings before interest, taxes, depreciation, and amortization of $30 million to $40 million.

RXO shares were up more than 3% in recent Wednesday pre-market activity.